Funder: National Institutes of Health

Due Dates: May 17, 2025 (Letter of Intent) | June 16, 2025 (New) | July 16, 2025 (Renewal/Resubmission/Revision) | September 16, 2025 (Letter of Intent) | October 16, 2025 (New) | November 16, 2025 (Renewal/Resubmission/Revision) | January 17, 2026 (Letter of Intent) | February 16, 2026 (New) | March 16, 2026 (Renewal/Resubmission/Revision) | May 17, 2026 (Letter of Intent) | June 16, 2026 (New) | July 16, 2026 (Renewal/Resubmission/Revision)

Funding Amounts: Up to $450,000 direct costs over 3 years; no more than $225,000 direct costs in any single year.

Summary: Supports R34 clinical trials to develop, pilot, or plan research on improving treatment and recovery for alcohol use disorder (AUD), including medications, behavioral therapies, health services, and reducing disparities.

Key Information: Clinical trial required; only human studies are allowed; foreign organizations are eligible.